<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02342938</url>
  </required_header>
  <id_info>
    <org_study_id>2011.698</org_study_id>
    <nct_id>NCT02342938</nct_id>
  </id_info>
  <brief_title>Simultaneous MEG or fMRI And INtracranial EEG</brief_title>
  <acronym>SEMAINE</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>Hospices Civils de Lyon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Konstanz</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hospices Civils de Lyon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The SEMAINE project will investigate intracranial EEG (icEEG) simultaneously recorded with&#xD;
      either fMRI or MEG to 1) improve identification of the epileptogenic zone in patients&#xD;
      suffering from drug-resistant partial epilepsy, and 2) define the functional organization of&#xD;
      neural networks underlying human perception and cognition in order to prevent inadvertent&#xD;
      deficits resulting from neurosurgical resection. In particular, high-frequency activity&#xD;
      (HFA), as measured with icEEG, has been demonstrated in recent years as a relevant index for&#xD;
      both epileptogenic tissue and healthy cortical processing, but its correlates in fMRI and MEG&#xD;
      require further investigation. This will be a pioneering effort in several respects, as the&#xD;
      first to directly measure high-frequency neural activity in tandem with fMRI, and among the&#xD;
      first to do so with MEG. In addition to their attractiveness as noninvasive imaging&#xD;
      techniques, fMRI and MEG have the potential to examine whole-brain networks that are not&#xD;
      accessible to icEEG's necessarily limited spatial coverage. Furthermore, such a campaign of&#xD;
      simultaneous recordings will take unprecedented advantage of icEEG as the bridge between the&#xD;
      two noninvasive techniques, providing compelling evidence for the links between all three&#xD;
      measurements with respect to underlying high-frequency neural activity in both health and&#xD;
      disease. This project will therefore lead to improved selection of epilepsy surgery&#xD;
      candidates and improved neurosurgical outcomes from the precise mapping of epileptogenic and&#xD;
      healthy brain networks. The same techniques will be immediately applicable to functional&#xD;
      mapping of other types of neurosurgery populations as well as diagnostic neuroimaging of&#xD;
      neurological and psychiatric populations.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 16, 2013</start_date>
  <completion_date type="Actual">May 18, 2017</completion_date>
  <primary_completion_date type="Actual">May 18, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Blood Oxygenation Level Dependent changes, associated with intracranial EEG signal, as determined by simultaneous fMRI and icEEG</measure>
    <time_frame>Month 2</time_frame>
    <description>fMRI correlates of epileptic and cognitive-induced high-frequency activities</description>
  </primary_outcome>
  <primary_outcome>
    <measure>MEG signal, associated with intracranial EEG signal, as determined by simultaneous MEG and icEEG</measure>
    <time_frame>Month 2</time_frame>
    <description>MEG correlates of epileptic and cognitive-induced high-frequency activities</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">47</enrollment>
  <condition>Epilepsy</condition>
  <condition>Healthy Volunteers</condition>
  <arm_group>
    <arm_group_label>Patient</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Volunteers</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>MEG or fMRI And INtracranial EEG</intervention_name>
    <arm_group_label>Volunteers</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>fMRI</intervention_name>
    <arm_group_label>Patient</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients aged between 18 and 60 years, not subject of any measure of legal protection&#xD;
&#xD;
          -  Patients suffering from drug resistant partial epilepsy&#xD;
&#xD;
          -  Patient undergoing intracranial video EEG&#xD;
&#xD;
          -  Patients with electrodes implanted in orthogonal&#xD;
&#xD;
          -  no MRI cons-indication&#xD;
&#xD;
          -  Patients who signed a consent form&#xD;
&#xD;
          -  Intellectual capacity to perform cognitive tasks and to sign an informed consent.&#xD;
&#xD;
          -  Affiliation to social security&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnant women&#xD;
&#xD;
          -  Elderly patients under 18 or over 60 years Patient not suffering from drug resistant&#xD;
             partial epilepsy, or not scheduled for a SEEG&#xD;
&#xD;
          -  MRI cons-indication&#xD;
&#xD;
          -  Patients taking psychotropics drugs&#xD;
&#xD;
          -  Claustrophobia&#xD;
&#xD;
          -  Inability to perform cognitive tasks or to give informed consent.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hospices Civils de Lyon</name>
      <address>
        <city>Lyon</city>
        <zip>69000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <study_first_submitted>October 6, 2014</study_first_submitted>
  <study_first_submitted_qc>January 15, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 21, 2015</study_first_posted>
  <last_update_submitted>February 1, 2018</last_update_submitted>
  <last_update_submitted_qc>February 1, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 5, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Epilepsy surgery</keyword>
  <keyword>High frequency activity</keyword>
  <keyword>icEEG</keyword>
  <keyword>fMRI</keyword>
  <keyword>MEG</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Epilepsy</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

